Fpgli M 4 Forte Tablet PR is a combination oral antidiabetic medication containing Glimepiride 4mg and Metformin 1000mg, designed to improve glycemic control in patients with type 2 diabetes mellitus. Glimepiride, a sulfonylurea class drug, stimulates pancreatic beta cells to release insulin, thereby lowering blood glucose levels. Metformin, a biguanide, works by decreasing hepatic glucose production, improving insulin sensitivity, and enhancing peripheral glucose uptake and utilization. This dual-action formulation helps manage blood sugar more effectively than either agent alone, making it suitable for patients inadequately controlled on diet, exercise, and monotherapy. The prolonged-release (PR) formulation ensures a steady release of the active ingredients, minimizing fluctuations in blood glucose and reducing gastrointestinal side effects commonly associated with Metformin. Fpgli M 4 Forte Tablet PR should be taken as prescribed by a healthcare professional, typically once or twice daily with meals to enhance absorption and reduce adverse effects. Regular monitoring of blood glucose levels, kidney function, and liver function is recommended during therapy. This medication is not suitable for patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, or known hypersensitivity to its components. Proper lifestyle modifications including diet and exercise should accompany pharmacotherapy for optimal diabetes management.

Dosage & How to Use